Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page

Cipla inaugurates a specialized lung health diagnostic facility in the nation’s capital, Delhi.

by Team Small News | Dec 1, 2025 | Cipla, Pharma

Cipla, a leading pharmaceutical company, has launched a dedicated lung health diagnostics centre in Delhi, India. This initiative is part of the company’s efforts to reimagine Indian healthcare and provide comprehensive care to patients with respiratory...

Cipla Inaugurates India’s Pioneer Comprehensive Lung Wellness Facility in Delhi

by Team Small News | Nov 29, 2025 | Cipla, Pharma

Cipla, a leading pharmaceutical company, has launched India’s first fully integrated Breathefree Lung Wellness Center in Delhi. The center, located in Lajpat Nagar, offers a comprehensive range of services, including over 60 diagnostic tests, pulmonary...

Indian pharmaceutical companies Cipla, Natco, Hetero, and Annora have secured major contracts to supply generic drugs to the Chinese market.

by Team Small News | Nov 12, 2025 | Cipla, Natco, Pharma

Cipla, Natco, Hetero, and Annora, four prominent Indian pharmaceutical companies, have secured significant contracts to supply generic drugs to China. This development marks a major breakthrough for Indian pharmaceutical companies in the Chinese market. The contracts...

Eli Lilly’s Mounjaro achieves ₹1 billion in monthly sales in India’s pharma market through partnership with Cipla.

by Team Small News | Nov 8, 2025 | Cipla, Pharma

Eli Lilly’s diabetes medication, Mounjaro, has achieved unprecedented success in India’s pharmaceutical market, crossing ₹1 billion in monthly sales. This remarkable feat is a result of the company’s strategic partnership with Cipla, a leading Indian...

Cipla Limited Announces Acquisition of 100% Stake in Inzpera Healthsciences at ₹110.65 Crore – geneonline.com

by Team Small News | Nov 4, 2025 | Cipla, Pharma

Cipla Limited, a leading pharmaceutical company, has announced its plans to acquire a 100% stake in Inzpera Healthsciences Private Limited, a healthcare startup, for a consideration of ₹110.65 crore. This acquisition is expected to strengthen Cipla’s presence in...

Cipla appoints Achin Gupta as its new CEO, effective April 2026, in addition to his current role as Chief Operating Officer.

by Team Small News | Nov 3, 2025 | Cipla, Pharma

Indian pharmaceutical company Cipla Ltd has announced a change in its leadership, with current Chief Operating Officer (COO) Achin Gupta set to take over as the company’s next Chief Executive Officer (CEO) and Managing Director. Gupta will succeed Umang Vohra,...
« Older Entries

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress